drugset / Trial / NCT04343274
Expanded Access for BLZ-100 (Tozuleristide)
Summary
This is the Blaze Bioscience expanded access program for its investigational drug tozuleristide intended for patients with life-threatening diseases or conditions who have exhausted approved treatment options and are unable to participate in a clinical trial involving the investigational drug tozuleristide.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | tozuleristide | Diagnostic / imaging agent | — | — |
Indications
No indication recorded.